Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT01177540 Terminated - Clinical trials for Pediatric Acute Myelogenous Leukemia (AML)

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Start date: March 3, 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to provide data on the activity of a standard daunorubicin, cytarabine, and etoposide (ADE) induction plus epigenetic priming with decitabine as assessed by standard measures of complete remission (CR), leukemia free survival (LFS) and overall survival (OS), as well as, on minimal residual disease (MRD). It will also provide necessary data on the safety and Pharmacokinetics (PK) of decitabine in pediatric patients that is currently unavailable.

NCT ID: NCT01175707 Terminated - Clinical trials for Complicated Skin or Skin Structure Infection

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Start date: July 15, 2010
Phase: Phase 4
Study type: Interventional

This is a randomized, open-label, multi-center, phase 4 study designed to compare intravenous (IV) daptomycin and IV vancomycin administered in a home infusion setting for the treatment of complicated skin and skin structure infections (cSSSI) due to Gram-positive bacteria in participants who are prescribed vancomycin for 7 to 14 days and who are planning to receive vancomycin in a home-infusion setting.

NCT ID: NCT01174199 Terminated - Prostate Cancer Clinical Trials

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Start date: February 2012
Phase: Phase 1
Study type: Interventional

RATIONALE: Temsirolimus and vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving temsirolimus together with vorinostat may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of temsirolimus and vorinostat in treating patients with metastatic prostate cancer.

NCT ID: NCT01169350 Terminated - Clinical trials for Recurrent Adult Soft Tissue Sarcoma

18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

Start date: February 2010
Phase: Phase 2
Study type: Interventional

This phase II trial is studying 18F-fluoromisonidazole and fludeoxyglucose F 18 PET/CT scans to see how well they work in assessing oxygen in tumor tissue of patients with soft tissue sarcoma undergoing chemotherapy with or without radiation therapy. Using diagnostic procedures, such as 18F-fluoromisonidazole and fludeoxyglucose F 18 PET scan and CT scan, to find oxygen in tumor cells may help in planning cancer treatment. It may also help doctors predict how well a patient will respond to treatment.

NCT ID: NCT01168024 Terminated - Clinical trials for Radiographic Contrast Agent Nephropathy

Contrast Media Reduction and Removal in Patients With CKD (PRESERV)

Start date: December 2012
Phase: Phase 3
Study type: Interventional

The purpose of this clinical trial is to demonstrate the efficacy and safety of the Osprey Medical CINCORâ„¢ Contrast Removal System.

NCT ID: NCT01167088 Terminated - Clinical trials for Non-alcoholic Fatty Liver Disease

A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)

MARVEL
Start date: November 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate whether a new medicine, called mitoquinone, will reduce raised liver enzymes due to NAFLD and to see if it is safe.

NCT ID: NCT01165619 Terminated - Clinical trials for Idiopathic Hypogonadotropic Hypogonadism

Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders

Start date: June 2010
Phase: N/A
Study type: Observational

In this study, we will measure levels of reproductive hormones and metabolic markers in subjects with isolated GnRH deficiency disorders and compare them to healthy control populations. Our goals are (1) to chart the range of hormonal and metabolic biomarkers in healthy subjects and those with reproductive disorders and (2) to correlate reproductive and metabolic phenotypes with genetic changes within patients with reproductive disorders and healthy controls.

NCT ID: NCT01165450 Terminated - Clinical trials for Persistent Corneal Epithelial Defects

Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects

NTX-PED-001
Start date: November 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Nexagon® in subjects with persistent corneal epithelial defects (PED) resulting from corneal epithelial debridement during diabetic vitrectomy surgery, HSV keratitis, HZV keratitis, corneal burns, post-PRK, or post-corneal transplant surgery.

NCT ID: NCT01164566 Terminated - Clinical trials for Stage IV Squamous Cell Carcinoma of the Hypopharynx

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Start date: December 2010
Phase: N/A
Study type: Interventional

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying esophagoscopy in evaluating treatment in patients with stage I-IV head and neck cancer who are undergoing radiation therapy and/or chemotherapy.

NCT ID: NCT01163526 Terminated - Colon Cancer Clinical Trials

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Start date: September 2010
Phase: N/A
Study type: Observational

A research study of liver perfusion (how blood flows to the liver over time). We hope to learn whether perfusion characteristics of liver masses may be predictive of response to treatment and whether liver perfusion characteristics can be used to follow response to treatment.